Gavyn Barrett
About Gavyn Barrett
Gavyn Barrett is the Director of Quality at Aimmune Therapeutics, where he has worked since 2019. He has extensive experience in quality assurance within the pharmaceuticals industry, having held various roles at notable companies including AstraZeneca, Takeda, and Norgine.
Work at Aimmune Therapeutics
Gavyn Barrett has been serving as the Director of Quality at Aimmune Therapeutics since 2019. In this role, he is responsible for overseeing quality assurance processes and ensuring compliance with regulatory standards for the company's products. His tenure at Aimmune Therapeutics spans five years, during which he has contributed to the development and implementation of quality assurance strategies tailored to the life sciences sector.
Previous Experience in Quality Assurance
Prior to his current position, Gavyn Barrett held several roles in quality assurance within the pharmaceutical industry. He worked at The Doctors Laboratory as Director of Quality from 2017 to 2019. His experience also includes positions at Takeda, where he served as Global QA Manager and Associate Director Clinical QA from 2012 to 2019. Additionally, he worked as a Quality Assurance Executive and Auditor at Norgine from 2004 to 2012, and as a QA Analyst at AstraZeneca from 2000 to 2002.
Education and Expertise
Gavyn Barrett studied at the University of Wales, Cardiff, where he earned a Bachelor of Science degree in Biomedical Science from 1997 to 2000. He possesses strong expertise in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP), which are essential for maintaining quality standards in the pharmaceutical industry. His educational background supports his extensive experience in quality oversight for both investigational and commercial products across the EU region.
Career Background in Pharmaceuticals
Gavyn Barrett has a demonstrated history of working in the pharmaceuticals industry, focusing on quality assurance. His career began at Penn Pharma as a QA/QC Assistant from 1996 to 1997. Over the years, he has developed and implemented quality assurance strategies that align with industry standards. His roles have spanned various companies and locations, including significant positions in London and Cardiff, contributing to his comprehensive understanding of quality management in the life sciences sector.